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Non-tuberculous mycobacteria (NTM) is a term used 
to refer to species of the genus Mycobacterium that 
are not included in the Mycobacterium tuberculosis 
complex (MTBc). These organisms are ubiquitous 
in nature, and can be recovered from a wide array of 
environmental sources.[1] NTM species are now increasingly being 
recognised as opportunistic pathogens capable of causing a spectrum 
of infections including pulmonary, lymphatic, skin and soft-tissue, 
and disseminated disease.[2]
More than 140 NTM species have been identified to date. Of 
these, 25 have been linked to human disease, exhibiting geographical 
variability with regard to prevalence of disease, species isolated and 
sites of infection. Identifying the NTM species, together with the 
site from which it was cultured, may be helpful in determining the 
clinical significance of the isolate.[3]
In the USA, M. avium complex was found to be the most common 
cause of NTM lung disease, followed by M. kansasii.[4] In England 
and Wales, disease is most commonly caused by M. kansasii, and in 
Scotland by M. malmoense.[5] In a locally based study, M. kansasii was 
the commonest isolate recovered from the sputum of miners.[6] To the 
best of our knowledge, there are no data available in South Africa (SA) 
on the spectrum of NTM species recovered from all clinical specimens.
It is well recognised that clinicians have great difficulty in distin-
guishing between disease caused by NTM and MTBc. Although 
microscopy for acid-fast bacilli (AFB) enables rapid diagnosis of 
mycobacteria, it cannot differentiate M. tuberculosis from NTM. This 
requires culture, which may take up to 6 weeks. Speciation of NTM 
in a routine laboratory traditionally required a battery of biochemical 
tests and observation of growth rate and colony morphology. However, 
this is time consuming, error prone and labour intensive, and requires 
experienced personnel for interpretation of results.[7] The introduction 
of molecular methods has led to a marked improvement in accuracy 
as well as turnaround time.
The GenoType Mycobacterium CM/AS (Hain Lifescience, Germany) 
is a commercial DNA strip assay based on reverse hybridisation of 
polymerase chain reaction products to their complementary probes. 
Although this molecular method is more expensive than the traditional 
methods, mycobacteria from positive liquid or solid cultures can be 
identified to species level rapidly and accurately.
The combination of the GenoType CM (for common mycobacteria) 
and Genotype AS (for additional species) allows for the detection of 
more than 40 clinically relevant mycobacteria species from cultured 
samples.[8]
Methods
This was a laboratory-based, prospective study to identify and 
speciate NTM isolated from specimens submitted to the National 
Health Laboratory Service (NHLS) central tuberculosis (TB) lab-
oratory at Inkosi Albert Luthuli Central Hospital (IALCH) from 
patients throughout the province of KwaZulu-Natal Province (KZN), 
SA. This is the only laboratory performing mycobacterial culture on 
specimens received from public healthcare centres in KZN.
Ethical approval was obtained from the Biomedical Research 
Ethics Committee at the University of KwaZulu-Natal.
A retrospective analysis of laboratory records for the year 2009 
revealed that the IALCH TB laboratory was isolating ±1 200 suspec-
ted NTM and ±10 000 MTBc annually from clinical specimens. In 
consultation with a statistician, it was agreed that 200 suspected 
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NTM, which comprised ±17% of the total number of NTM cultured 
annually, should be speciated to provide a statistically significant 
sample.
Random sampling for a period of 1 year was performed 
(January 2010 - December 2010). All specimens submitted for TB 
culture were processed according to the TB laboratory standard 
operating procedure. Samples included sputum, endotracheal 
aspirates, brochoalveolar lavage, sterile fluid, biopsy tissue, blood 
and cerebrospinal fluid. Isolates suspected to be NTM by colony 
morphology, biochemical tests (niacin and nitrate) and/or the SD 
Bioline TB Ag MPT64 Rapid Test were investigated further by a 
commercially available molecular test that speciates NTM. The 
GenoType Mycobacterium CM/AS was used to identify suspected 
NTM from liquid (BACTEC MGIT 960, Becton Dickinson, USA) 
or solid (Middlebrook 7H11; Becton Dickinson) culture media. 
DNA was extracted from the stored cultures according to the 
manufacturer’s instructions. The GenoType assay was performed 
strictly according to the manufacturer’s package insert.
The demographic characteristics of patients from whom the 
NTM was recovered were extracted from the NHLS TB laboratory 
database, and data analysis was performed using Microsoft Excel. 
Confidentiality of patient information was maintained throughout 
the study.
Results
Of a total of 200 suspected NTM cultures from 200 individual 
patients, 133 (66.5%) were confirmed as NTM by the molecular 
assay. Of these 133 NTM, 114 were fully speciated by the molecular 
assay; 8 could not be speciated further as the molecular assays only 
contain probes that allow for the detection of 40 commonly isolated 
NTM, and the remaining 11 represented mixed NTM species. An 
additional 6 cultures were identified as MTBc, and the remaining 61 
cultures could not be speciated owing to contamination or an absence 
of mycobacterial DNA (Table 1).
Of the 133 NTM species, M. intracellulare (n=61, 45.9%), M. avium 
subspecies (ssp.) (n=15, 11.3%), M. gordonae (n=8, 6.0%) and 
M. kansasii (n=6, 4.5%) accounted for 90 (67.7%) of isolates (Fig. 1).
All NTM were cultured from respiratory specimens, with the 
exception of an M. gordonae isolate that was cultured from a biopsy 
sample and an M. intracellulare isolate from a gastric washing.
Fifty-eight (43.6%) of the NTM isolates were cultured from 
patients attending healthcare facilities in the eThekwini (Durban) 
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Fig. 1. Common Mycobacterium species isolated during the year 2010. 
Table 1. Identification of suspected NTM
Organism Isolates, n
NTM 133
M. abscessus 5
M. asiaticum 2
M. avium ssp. 15
M. chelonae 5
M. fortuitum 4
M. gordonae 8
M. heckeshornense 1
M. interjectum 2
M. intracellulare 61
M. kansasii 6
M. lentiflavum 1
M. malmoense 1
M. scrofulaceum 3
NTM not speciated 8
Mixed NTM species 11
MTBc 6
Cultures with no mycobacterial DNA 54
Contaminated cultures 7
Total 200
NTM = non-tuberculous mycobacteria; M. = Mycobacterium; 
MTBc = M. tuberculosis complex. 
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district. This was followed by 20 (15.0%) and 11 (8.3%) isolates from 
the Umkhanyakude and Uthungulu districts, respectively.
Discussion
In recent years there has been an increased awareness of NTM 
as disease-causing agents, especially in the growing HIV-infected 
population as well as in other immunosuppressed patients.
In countries with high prevalence rates of M. tuberculosis, patients 
in whom AFB are detected on microscopy or culture are generally 
assumed to have TB and treated as such. The incorrect diagnosis 
leads to unnecessary and/or incorrect treatment of many patients 
who are in fact colonised or infected with NTM.[9]
The most common species of NTM identified during the study 
period was M. intracellulare (45.9%), followed by M. avium ssp. 
(11.3%). These two species are often referred to as M. avium complex 
(MAC) and cannot be differentiated using phenotypic tests. There 
are, however, specific DNA probes in the molecular tests that allow 
for speciation of these two closely related and commonly isolated 
NTM. In this study, MAC accounted for 76 (57.1%) of the 133 NTM 
isolates.
Six per cent of the cultured NTM were identified as M. gordonae. 
In the majority of cases this organism is considered to be non-
pathogenic, and it is the most commonly isolated mycobacterial 
contaminant.[10]
M. kansasii, which is the most common agent causing NTM 
disease in England and Wales, made up only 4.5% of NTM isolated 
in this study. Generally, tap water is reported to be the most frequent 
environmental source of this organism; infection may lead to lung 
disease that closely resembles tuberculosis.[10]
The spectrum and distribution of NTM in sub-Saharan Africa is 
not well known, as most data originate from the more developed 
nations in Northern Europe and North America. This may not 
necessarily be due to a low incidence of NTM disease in developing 
countries, but rather result from less priority being given to NTM 
in regions where the TB burden is overwhelming. Buijtels et al.[11] 
reported that in Zambia, a country with a high prevalence of TB, 
MAC was the most frequently isolated NTM. Similarly, a study 
identifying NTM from clinical specimens in Ethiopia showed MAC 
to be the predominant species, followed by M. abscessus, M. gordonae, 
M. simiae and M. fortuitum.[12] The high frequency of isolation of 
MAC in both studies is in keeping with our findings. In an SA study 
of NTM in miners, the two most common isolates were M. kansasii 
(n=56) and M. scrofulaceum (n=14); only three of the isolates were 
identified as M. avium ssp.[6] This is in contrast to our study, where 
MAC predominated, with M. kansasii making up only 4.5% of NTM 
recovered.
Ninety-three per cent of the NTM isolates were cultured from 
sputum. This is not surprising, as pulmonary TB remains the 
commonest form of TB in SA, hence the predominance of sputum 
samples being submitted for TB culture. Lung disease is also regarded 
as the most frequent clinical manifestation of NTM disease.[10]
The province of KZN is divided geographically into 11 healthcare 
districts. Fifty-eight (43.6%) of the NTM originated from patients 
presenting to healthcare facilities in the eThekwini (Durban) 
district. Twenty-one (36.2%) of these isolates were identified as M. 
intracellulare. This organism was also found to be the predominant 
NTM in all districts with the exception of Uthukela, where M. avium 
ssp. was the most common isolate. The high burden of TB disease 
in the eThekwini district, which has a large TB clinic as well as a TB 
referral hospital, may have resulted in a larger number of specimens 
being submitted for TB culture. This possibly accounted for the 
highest proportion of NTM being found in this district, rather than 
indicating a greater risk of NTM exposure.
Study limitations
This study had certain limitations. The absence of clinical and 
radiological data precluded determining the clinical significance 
of the NTM isolates. As a result, we could not determine whether 
disease was indeed due to a NTM, or if the organism was merely a 
contaminant. Furthermore, as a result of the long incubation period 
required for mycobacteria, many of the culture plates were found to 
be overgrown with non-mycobacterial contaminants, hindering the 
molecular process of identification.
Conclusion
The most common NTM isolated from patients with suspected 
mycobacterial disease were M. intracellulare and M. avium ssp., 
which is in keeping with findings elsewhere in the world. We believe 
that it is important for laboratories to document the local spectrum 
of NTM, even in developing countries, because of the geographical 
variation in the different NTM species isolated. Although the 
molecular tests for identifying NTM are relatively expensive and 
require expertise, they have the advantage of providing rapid and 
accurate identification of the various NTM species.
Acknowledgement. This research was conducted at the NHLS central 
tuberculosis laboratory, IALCH, KwaZulu-Natal, SA.
References
1. Falkinham JO III. The changing pattern of nontuberculous mycobacterial disease. Can J Infect Dis 
2003;14(5):281-286.
2. Chetchotisakd P, Kiertiburanakul S, Mootsikopun P, Assanasen S, Chaiwarith R, Anunnatsiri S.
Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in 
Thailand. Clin Infect Dis 2007;45(4):421-427. [http://dx.doi.org/10.1086/520030]
3. Van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med
2013;34(1):109-109. [http://dxdoi.org/10.1055/s-0033-1333569]
4. O’Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the 
United States: Results from a national survey. Am Rev Respir Dis 1987;135(5):1007-1014.
5. British Thoracic Society. Management of opportunistic mycobacterial infections: Joint Tuberculosis 
Committee Guidelines 1999. Thorax 2000;55(3):210-218. [http://dx.doi.org/10.1136/thorax.55.3.210]
6. Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: Defining disease in a 
prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160(1):15-21. [http://
dx.doi.org/10.1164/ajrccm.160.1.9812080]
7. Cook VJ, Turenne CY, Wolfe J, Pauls R, Kabani A. Conventional methods versus 16S ribosomal
DNA sequencing for identification of nontuberculous mycobacteria: Cost analysis. J Clin Microbiol 
2003;41(3):1010-1015. [http://dx.doi.org/10.1128/JCM.41.3.1010-1015.2003]
8. Hain Lifescience. GenoType® Mycobacterial CM/AS. http://www.hain-lifescience.co.za/products/
microbiology/mycobacteria/genotype-mycobacterium-cmas.html (accessed 10 March 2010).
9. Jesudason MV, Gladstone P. Non tuberculous mycobacteria isolated from clinical specimens at a
tertiary care hospital in South India. Indian J Med Microbiol 2005;23(3):172-175. [http://dx.doi.
org/10.4103/0255-0857.16589]
10. Griffith DE, Aksamit T, Brown-Elliot BA, et al. An official ATS/IDSA statement: Diagnosis, treatment, 
and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175(4):367-
416. [http://dx.doi.org/10.1164/rccm.200604-571ST]
11. Buijtels PCAM, van der Sande MAB, de Graaff CS, et al. Nontuberculous mycobacteria, Zambia.
Emerg Infect Dis 2009;15(2):242-249. [http://dx.doi.org/10.3201/eid1502.080006]
12. Girmachew F. Identification on nontuberculosis mycobacteria from clinical specimens referred to
national TB reference laboratory, Ethiopia. Presented at the 8th TB Research Advisory Committee 
(TRAC) Conference, 23 March 2013, Addis Ababa, Ethiopia. http://ehnri.gov.et/TRAC%20CON/
Day%20Three/Feven%20EDITED%20Presentation.pdf (accessed 12 June 2013).
Accepted 2 June 2014.
